menu
    • menu

    Company profile for RVAC Medicines

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    RVAC Medicines has established a team of top-tiered talents in fields of mRNA, vaccines, and lipid nanoparticle (LNP) technologies. We are working to establish a pipeline of innovative products to treat infectious and other diseases with unmet needs. Through our efforts, RVAC Medicines will provide additional protections to ASEAN countries against COVID-19 and SARS-CoV2 variants, as well as innovative treatments against other ...
    RVAC Medicines has established a team of top-tiered talents in fields of mRNA, vaccines, and lipid nanoparticle (LNP) technologies. We are working to establish a pipeline of innovative products to treat infectious and other diseases with unmet needs. Through our efforts, RVAC Medicines will provide additional protections to ASEAN countries against COVID-19 and SARS-CoV2 variants, as well as innovative treatments against other infectious diseases. To enable this mission and achieve our goals, we are establishing cutting-edge GMP manufacturing facilities that will advance our platform technologies.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    RVAC MedicinesUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    200 Boston Avenue, Suite 1875, Medford, Massachusetts 02155
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.rvacmed.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/rvac-medicines/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    RVAC Secures HSA Approval to Initiate Phase 1B Clinical Trial in Singapore
    RVAC Secures HSA Approval to Initiate Phase 1B Clinical Trial in Singapore

    20 Feb 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/rvac-medicines-secures-hsa-approval-to-initiate-phase-1b-clinical-trial-in-singapore-301750718.html

    PR NEWSWIRE
    20 Feb 2023
    Share Share
    RVAC Medicines and A*STAR Sign Research Collaboration Agreement
    RVAC Medicines and A*STAR Sign Research Collaboration Agreement

    21 Nov 2022

    // CONTRACTPHARMA

    https://www.contractpharma.com/contents/view_breaking-news/2022-11-21/rvac-medicines-and-astar-sign-research-collaboration-agreement/?widget=listSection

    CONTRACTPHARMA
    21 Nov 2022
    Share Share
    RVAC Medicines Initiates Clinical Trials for mRNA COVID-19 Vaccine Candidates
    RVAC Medicines Initiates Clinical Trials for mRNA COVID-19 Vaccine Candidates

    21 Sep 2022

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/rvac-medicines-initiates-first-in-human-clinical-trials-for-mrna-covid-19-vaccine-candidates-301629731.html

    PRNEWSWIRE
    21 Sep 2022
    Share Share
    RVAC Medicines Raises US$140M to Expand R&D and Manufacturing Capacity
    RVAC Medicines Raises US$140M to Expand R&D and Manufacturing Capacity

    26 Apr 2022

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/rvac-medicines-a-cbc-incubated-mrna-platform-company-raises-us140-million-to-expand-rd-and-manufacturing-capacity-301533302.html

    PRNEWSWIRE
    26 Apr 2022
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search